19 May 2013
Keywords: biocryst, agrees, spa, pivotal, oral, fodosine, trial
Article | 16 July 2007
Alabama, USA-based BioCryst Pharmaceuticals says that it has reached an agreement with the Food and Drug Administration under its Special
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 July 2007
17 May 2013
© 2013 thepharmaletter.com